par Moretti, Erica;Desmedt, Christine
;Biagioni, Chiara;Regan, Meredith M;Oakman, Catherine;Larsimont, Denis
;Galardi, Francesca;Piccart-Gebhart, Martine
;Sotiriou, Christos
;Rimm, David D.L.;Di Leo, Angelo 
Référence Future oncology, 9, 10, page (1477-1487)
Publication Publié, 2013-10





Référence Future oncology, 9, 10, page (1477-1487)
Publication Publié, 2013-10
Article révisé par les pairs
Résumé : | Anthracyclines are commonly used in breast cancer, although they lack validated predictive biomarkers. We explored the interaction between TOP2A protein by quantitative immunofluorescence (QIF) and anthracycline sensitivity. |